Modeling VEGFR kinase inhibition of aminopyrazolopyridine urea derivatives using topological and physicochemical descriptors: a quantitative structure activity analysis study

被引:0
作者
Ashutosh Kumar Pandey
Omprakash Tanwar
Girdhar Singh Deora
Chandrabose Karthikeyan
N. S. Hari Narayana Moorthy
Piyush Trivedi
机构
[1] Rajiv Gandhi Proudyogiki Vishwavidyalaya,School of Pharmaceutical Sciences
来源
Medicinal Chemistry Research | 2012年 / 21卷
关键词
Angiogenesis; Aminopyrazolopyridine urea; VEGFR; QSAR;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3958 / 3964
页数:6
相关论文
共 173 条
[1]  
Assefa H(2003)3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors J Comput Aided Mol Des 17 475-493
[2]  
Kamath S(2003)Pharmacological characterization of CP-547, 632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy Cancer Res 63 7301-7309
[3]  
Buolamwini JK(2009)Quantitative structure activity relationship studies of piperazinyl phenylalanine as VLA-4/VCAM-1 Inhibitors Med Chem 5 446-454
[4]  
Beebe JS(2007)3D QSAR studies on a series of potent and high selective inhibitors for three kinases of RTK family J Mol Graph Model 26 236-245
[5]  
Jani JP(2008)Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitors Bioorg Med Chem Lett 18 386-390
[6]  
Knauth E(2004)Simple stochastic fingerprints towards mathematical modelling in biology and medicine. 1. The treatment of coccidiosis Bull Math Biol 66 1285-1311
[7]  
Goodwin P(2009)Molecular modeling studies of vascular endothelial growth factor receptor tyrosine kinase inhibitors using QSAR and docking J Mol Graph Model 27 642-654
[8]  
Higdon C(2003)A new class of potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: structure-activity relationships for a series of 9-alkoxymethyl-12-(3-hydroxypropyl)indeno[2,1-a]pyrrolo[3,4-c]carbazole-5-ones and the identification of CEP-5214 and its dimethylglycine ester prodrug clinical candidate CEP-7055 J Med Chem 46 5375-5388
[9]  
Rossi AM(2006)Modeling of farnesyltransferase inhibition by some thiol and non-thiol peptidomimetic inhibitors using genetic neural networks and RDF approaches Bioorg Med Chem 14 200-213
[10]  
Emerson E(2003)Markovian chemicals “in silico” design (MARCH-INSIDE), a promising approach for computer-aided molecular design I: discovery of anticancer compounds J Mol Model 9 395-407